ClinicalTrials.gg
Sign In

Epilepsies, Partial clinical trials

The registry lists 243 studies for Epilepsies, Partial across more than 10 countries. 49 are recruiting or about to start. 186 of them are mainly about Epilepsies, Partial (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 2 narrower conditions too, such as Epilepsy, Temporal Lobe: 323 studies, 73 open.

Get an email when these change. Save the Epilepsies, Partial studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
138
Recruiting
37
Terminated
22
Status unknown
16
Active, not recruiting
9
Not yet recruiting
7

Phase

Phase 3
68
Phase 2
46
Phase 4
30
Phase 1
10
Early Phase 1
2

Where

United States
102
France
40
Germany
33
Poland
26
Australia
22
Spain
22

Who runs them

UCB Pharma (17) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (15) · SK Life Science, Inc. (13) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (12) · National Institute of Neurological Disorders and Stroke (NINDS) (11) · Pfizer (8) · GlaxoSmithKline (7) · Bial - Portela C S.A. (7)

What is being tested here

Drugs under test in Epilepsies, Partial studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
RAP-219324
SPN-817202
Cenobamate126
Lamotrigine136
Opakalim123
XEN1101112
Zonisamide102
Probenecid101
CB03-154101
Butylphthalide101

Drug classes tested here Anxiolytics 3

Coming up

7phase 3 studies under way
19studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 37 Epilepsies, Partial studies recruiting now, 9 (24%) set no upper age limit and 24 (65%) stop at 75 or younger. 17 (46%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (8%) take healthy volunteers.

Recruiting studies that take each age, of 37
AgeWomenMen
1015 (41%)15 (41%)
1832 (86%)32 (86%)
3028 (76%)28 (76%)
4028 (76%)28 (76%)
5027 (73%)27 (73%)
6524 (65%)24 (65%)
7516 (43%)16 (43%)
8512 (32%)12 (32%)

Across all 243 studies, recruiting or not: 55% stop at 75 or younger and 41% at 65; 46% take children; <1% are for women only and 1% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 12, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 243. Browse all 243 → or search them.